Insights Regarding the Role of Inflammasomes in Leukemia: What Do We Know?
Authors:
- Fabíola Silva Alves-HannaFAFabíola Silva Alves-Hanna
- Juniel Assis Crespo-NetoJCJuniel Assis Crespo-Neto
- Glenda Menezes NogueiraGNGlenda Menezes Nogueira
- Daniele Sá PereiraDPDaniele Sá Pereira
- Amanda Barros LimaALAmanda Barros Lima
- Thaís Lohana Pereira RibeiroTRThaís Lohana Pereira Ribeiro
- Vitória Giovanna Rodrigues SantosVSVitória Giovanna Rodrigues Santos
- Joey Ramone Ferreira FonsecaJFJoey Ramone Ferreira Fonseca
- Fábio Magalhães-GamaFMFábio Magalhães-Gama
- Aya SadahiroASAya Sadahiro
- Allyson Guimarães CostaACAllyson Guimarães Costa
Open Access
- 4 August 2023
- journal article
- review article
- Published by Wiley in Journal of Immunology Research
- Vol. 2023, 1-15
Abstract
Inflammation is a physiological mechanism of the immune response and has an important role in maintaining the hematopoietic cell niche in the bone marrow. During this process, the participation of molecules produced by innate immunity cells in response to a variety of pathogen-associated molecular patterns and damage-associated molecular patterns is observed. However, chronic inflammation is intrinsically associated with leukemogenesis, as it induces DNA damage in hematopoietic stem cells and contributes to the creation of the preleukemic clone. Several factors influence the malignant transformation within the hematopoietic microenvironment, with inflammasomes having a crucial role in this process, in addition to acting in the regulation of hematopoiesis and its homeostasis. Inflammasomes are intracellular multimeric complexes responsible for the maturation and secretion of the proinflammatory cytokines interleukin-1β and interleukin-18 and the cell death process via pyroptosis. Therefore, dysregulation of the activation of these complexes may be a factor in triggering several diseases, including leukemias, and this has been the subject of several studies in the area. In this review, we summarized the current knowledge on the relationship between inflammation and leukemogenesis, in particular, the role of inflammasomes in different types of leukemias, and we describe the potential therapeutic targets directed at inflammasomes in the leukemic context.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado do Amazonas (#002/2008, #007/2018, #005/2019, #005/2022, #002/2023, #88887.707248/2022-00)
- POSGRAD (#002/2008, #007/2018, #005/2019, #005/2022, #002/2023, #88887.707248/2022-00)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#002/2008, #007/2018, #005/2019, #005/2022, #002/2023, #88887.707248/2022-00)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (#002/2008, #007/2018, #005/2019, #005/2022, #002/2023, #88887.707248/2022-00)
This publication has 114 references indexed in Scilit:
- NLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor CellsImmunity, 2012
- DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori–specific immune tolerance, and asthma protectionJournal of Clinical Investigation, 2012
- A clinical perspective of IL‐1β as the gatekeeper of inflammationEuropean Journal of Immunology, 2011
- Role of the Inflammasome, IL-1, and IL-18 in Bacterial InfectionsThe Scientific World Journal, 2011
- Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4Journal of Leukocyte Biology, 2009
- HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNAScience, 2009
- NALP1 is a transcriptional target for cAMP-response-element-binding protein (CREB) in myeloid leukaemia cellsBiochemical Journal, 2004
- Correlation of polymorphic variation in the promoter region of the interleukin‐1β gene with secretion of interleukin‐1β proteinArthritis & Rheumatism, 2004
- The PYRIN-CARD Protein ASC Is an Activating Adaptor for Caspase-1Journal of Biological Chemistry, 2002
- Interleukin 1 (IL-1α and IL-1β) induces differentiation/activation of B cell chronic lymphoid leukemia cellsCytokine, 1994